3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
270
Stomach Neoplasms
200
Rectal Neoplasms
180
Pancreatic Neoplasms
131
Colonic Neoplasms
112
Neoplasm Metastasis
74
Esophageal Neoplasms
63
Carcinoma, Hepatocellular
41
Neoplasms
40
Cholangiocarcinoma
36
Adenocarcinoma Of Esophagus
32
Adenocarcinoma
32
Biliary Tract Neoplasms
25
Liver Neoplasms
21
Gallbladder Neoplasms
21
Recurrence
18
Gastrointestinal Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
17
Peritoneal Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
16
Esophageal Squamous Cell Carcinoma
14
Locally Advanced Rectal Cancer
12
Bile Duct Neoplasms
11
Colorectal Cancer Metastatic
8
Unspecified Adult Solid Tumor, Protocol Specific
7
Ovarian Neoplasms
7
Lymphoma, Extranodal NK-T-Cell
7
Head and Neck Neoplasms
7
Appendiceal Neoplasms
7
Interventions
Cyclophosphamide
21
Cytarabine
15
blinatumomab
13
fludarabine
12
Azacitidine
10
venetoclax
9
fludarabine phosphate
9
Blood Specimen Collection
8
Methotrexate
7
Lenalidomide
7
Dexamethasone
7
Rituximab
6
Mercaptopurine
6
Daunorubicin
6
Vincristine
5
daratumumab
4
Whole-Body Irradiation
4
Melphalan
4
Etoposide
4
Busulfan
4
obinutuzumab
3
Radiotherapy
3
Neoadjuvant Therapy
3
Maintenance
3
Liquid Biopsy
3
Immunotherapy, Adoptive
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Drug Therapy
3
Doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm, Residual
×
Oxaliplatin
×
Clear all
NCT05427669
2022-10-07
AFFORD
Sun Yat-sen University
Phase 3
Not yet recruiting
340 enrolled